cookieImage
2026-2027 / Master

Pharmacy, professional focus in community pharmacy management and professional issues (Réinscription uniquement, pas de nouvelle inscription)

120 crédits
Master in pharmacy, professional focus in community pharmacy management and professional issues (Réinscription uniquement, pas de nouvelle inscription)
M2SOFF01

Cycle view

  • Bloc
  • Organization
  • Theory
  • Practical
  • Others
  • Credits

Core curriculum courses

B1
55Cr
B2
35Cr
CodeDetailsBlocOrganizationTheoryPracticalOthersCredits
Medicine analysis - [10h Seminar] B1Q13628[+]7
Pharmaceutical technologies and biopharmacy (part I) B1Q12060-4
Special pharmacology (Part I) B1Q125--3
Toxiocological chemistry, Part IB1Q1   4
Toxiocological chemistry   25-- 
Toxicological chemistry, supplement for pharmacy - [12h Seminar]   --[+] 
Clinical Chemistry (Part I) - [12h Seminar] B1Q122-[+]4
Pharmaceutical Microbiology B1Q116--2
Good officinal pharmaceutical practice - [2h Seminar] B1Q112-[+]2
Pharmacoeconomy B1Q110--1
Pharmaceutical tehcnologies and biopharmacy (part II) - [5h Seminar]
Corequisite
PHAR0343-3
Technologie pharmaceutique et biopharmacie (partim I)
B1Q225-[+]4
Practical work - Pharmaceutical technologies and Biopharmacy
Corequisite
PHAR0003-1
Technologie pharmaceutique et biopharmacie (partim II)
B1Q2-32-2
Special pharmacology (Part II)
Corequisite
PHAC0341-2
Pharmacologie spéciale (Partim I)
B1Q220--2
Clinical Toxicology and adverse drug events monitoring (Part II) - [12h Seminar]
Corequisite
TOXI0341-2
Chimie toxicologique, Partim I
B1Q225-[+]4
Clinical chemistry (2nd part) - [12h Seminar]
Corequisite
BIOC0340-1
Chimie clinique (Partim I)
B1Q223-[+]4
Pharamcotherapy and pharmaceutical cares - [10h Seminar] B1Q230-[+]4
Therapeutic approach - [20h Séminaire Interdisciplinaire] B1Q2--[+]2
Legislation and pharmaceutical ethics B1Q230--3
Practical integrated work
Corequisite
PHAR0003-1
Technologie pharmaceutique et biopharmacie (partim II)
PHAR0343-3
Technologie pharmaceutique et biopharmacie (partim I)
PHAR0344-3
Analyse des médicaments
B1Q2-32-2
Innovative therapy medications B1Q210--1
Interdisciplinarity and vaccinationB2Q2   1
Interdisciplinarity - [12h Seminar]   22[+] 
Vaccination - [8h Seminar]
Corequisite
MTFE0351-3
Stage officinal, travail de fin d'études et visites industrielles
  --[+] 
Incorporation of pharmaceutical knowledge
Corequisite
MTFE0351-3
Stage officinal, travail de fin d'études et visites industrielles
B2Q2---5

Compulsory Training

Officinal internship, thesis, and industrial visitsB2TA   29
Learning file and participation in the clinical research project - [100h Personal research]   --[+] 
Officinal internship - [6mois internship]   --[+] 
Industrial visits - [120h Visit]
Prerequisite
TOXI0342-2
Chimie toxicologique y compris pharmacovigilance (Partim II)
PHAR2018-1
Bonnes pratiques pharmaceutiques officinales
PHAR0347-3
Travaux pratiques - Technologie pharmaceutique et biopharmacie
PHAR0343-3
Technologie pharmaceutique et biopharmacie (partim I)
PHAR0003-1
Technologie pharmaceutique et biopharmacie (partim II)
PHAC0342-2
Pharmacologie spéciale (Partim II)
PHAC0341-2
Pharmacologie spéciale (Partim I)
LEGI0340-2
Législation et déontologie pharmaceutiques
BIOC0341-1
Chimie clinique (Partim II)
Corequisite
PHAR0721-1
Intégration des connaissances pharmaceutiques
  --[+] 
Notice : students must do a placement in a pharmacy of a legal duration of six months (26 weeks), and compile a learning record (dissertation) at the same time. This placement includes a compulsory introductory two-week internship, during the summer, after the bachelor's degree. For students who have acquired a minimum of 45 ECTS from block 1 of the master's degree, they can do their placement in a pharmacy during the summer holidays before starting block 2 of the master's degree (maximum 8 weeks). The remaining number of weeks (minimum 16 weeks) can be done within the framework of block 2 of the master's (2nd term).

Focus courses

B1
5Cr
B2
25Cr
CodeDetailsBlocOrganizationTheoryPracticalOthersCredits
Specific courses for the professional focus in officinal practice and pharmaceutical management (Term 2)B1Q2   5
At-risk populations: paediatrics / pregnancy and breastfeeding / geriatrics - [4h Seminar]   6-[+] 
Medication review and prescription analysis, including pharmacokinetics applied to community pharmacy - [6h Seminar]   4-[+] 
Dermopharmacy, including first aid in community pharmacy - [2h Seminar]   8-[+] 
Phytotherapy, aromatherapy, homeopathy and nutrients - [6h Seminar]   4-[+] 
Doping, misuse and abuse of medicinal products, including cessation support and communication - [5h Seminar]   5-[+] 
Specific courses for the professional focus in officinal practice and pharmaceutical management (Term 1)B2Q1   5
Community pharmacy accounting   10-- 
Company and individual law   10-- 
Community pharmacy administration - [4h Seminar]   6-[+] 
Community pharmacy taxation   10-- 
Pricing policy in community pharmacy - [4h Seminar]   6-[+] 
Internship in pharmaceutical management - [210h internship] B2Q1--[+]8
Personal research linked to the internship in pharmaceutical management - [20h Supervision of internship, 40h Personal research] B2Q1--[+]7
Professional development Seminar - [30h Learning based on problem-solv]
Corequisite
MTFE0351-3
Stage officinal, travail de fin d'études et visites industrielles
B2Q2--[+]5